Related Experiment Video
Updated: Jan 11, 2026

In vitro Assessment of Aortic Regurgitation Using Four-Dimensional Flow Magnetic Resonance Imaging
Published on: February 25, 2022
Transcatheter Heart Valves with Labelling for Aortic Regurgitation
Pier Pasquale Leone1, Azeem Latib1
1Division of Cardiology, Montefiore Medical Center Bronx, New York, NY, US.
None:
Treatment of pure aortic regurgitation (AR) has historically been addressed via surgical aortic valve repair or replacement. A less invasive option for patients affected by AR has been attempted with the advent of transcatheter aortic valve replacement (TAVR). Here, we review the rationale, benefits and challenges of TAVR for the treatment of native pure AR. In particular, we explore upcoming dedicated technologies with labelling for transcatheter treatment of AR, detailing both device and procedural specifics. Finally, evidence from recent studies conducted in patients with pure AR is appraised in light of available evidence from TAVR with non-dedicated devices in this setting.
More Related Videos
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Aortic Regurgitation IV: Nursing Management
Aortic Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation III: Medical Management

